Cargando…

The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase

[Image: see text] Indoleamine 2,3-dioxygenase catalyzes the O(2)-dependent oxidation of l-tryptophan (l-Trp) to N-formylkynurenine (NFK) as part of the kynurenine pathway. Inhibition of enzyme activity at high l-Trp concentrations was first noted more than 30 years ago, but the mechanism of inhibiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Efimov, Igor, Basran, Jaswir, Sun, Xiao, Chauhan, Nishma, Chapman, Stephen K., Mowat, Christopher G., Raven, Emma Lloyd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280726/
https://www.ncbi.nlm.nih.gov/pubmed/22299628
http://dx.doi.org/10.1021/ja208694g
_version_ 1782223854738866176
author Efimov, Igor
Basran, Jaswir
Sun, Xiao
Chauhan, Nishma
Chapman, Stephen K.
Mowat, Christopher G.
Raven, Emma Lloyd
author_facet Efimov, Igor
Basran, Jaswir
Sun, Xiao
Chauhan, Nishma
Chapman, Stephen K.
Mowat, Christopher G.
Raven, Emma Lloyd
author_sort Efimov, Igor
collection PubMed
description [Image: see text] Indoleamine 2,3-dioxygenase catalyzes the O(2)-dependent oxidation of l-tryptophan (l-Trp) to N-formylkynurenine (NFK) as part of the kynurenine pathway. Inhibition of enzyme activity at high l-Trp concentrations was first noted more than 30 years ago, but the mechanism of inhibition has not been established. Using a combination of kinetic and reduction potential measurements, we present evidence showing that inhibition of enzyme activity in human indoleamine 2,3-dioxygenase (hIDO) and a number of site-directed variants during turnover with l-tryptophan (l-Trp) can be accounted for by the sequential, ordered binding of O(2) and l-Trp. Analysis of the data shows that at low concentrations of l-Trp, O(2) binds first followed by the binding of l-Trp; at higher concentrations of l-Trp, the order of binding is reversed. In addition, we show that the heme reduction potential (E(m)(0)) has a regulatory role in controlling the overall rate of catalysis (and hence the extent of inhibition) because there is a quantifiable correlation between E(m)(0) (that increases in the presence of l-Trp) and the rate constant for O(2) binding. This means that the initial formation of ferric superoxide (Fe(3+)–O(2)(•–)) from Fe(2+)-O(2) becomes thermodynamically less favorable as substrate binds, and we propose that it is the slowing down of this oxidation step at higher concentrations of substrate that is the origin of the inhibition. In contrast, we show that regeneration of the ferrous enzyme (and formation of NFK) in the final step of the mechanism, which formally requires reduction of the heme, is facilitated by the higher reduction potential in the substrate-bound enzyme and the two constants (k(cat) and E(m)(0)) are shown also to be correlated. Thus, the overall catalytic activity is balanced between the equal and opposite dependencies of the initial and final steps of the mechanism on the heme reduction potential. This tuning of the reduction potential provides a simple mechanism for regulation of the reactivity, which may be used more widely across this family of enzymes.
format Online
Article
Text
id pubmed-3280726
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-32807262012-02-16 The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase Efimov, Igor Basran, Jaswir Sun, Xiao Chauhan, Nishma Chapman, Stephen K. Mowat, Christopher G. Raven, Emma Lloyd J Am Chem Soc [Image: see text] Indoleamine 2,3-dioxygenase catalyzes the O(2)-dependent oxidation of l-tryptophan (l-Trp) to N-formylkynurenine (NFK) as part of the kynurenine pathway. Inhibition of enzyme activity at high l-Trp concentrations was first noted more than 30 years ago, but the mechanism of inhibition has not been established. Using a combination of kinetic and reduction potential measurements, we present evidence showing that inhibition of enzyme activity in human indoleamine 2,3-dioxygenase (hIDO) and a number of site-directed variants during turnover with l-tryptophan (l-Trp) can be accounted for by the sequential, ordered binding of O(2) and l-Trp. Analysis of the data shows that at low concentrations of l-Trp, O(2) binds first followed by the binding of l-Trp; at higher concentrations of l-Trp, the order of binding is reversed. In addition, we show that the heme reduction potential (E(m)(0)) has a regulatory role in controlling the overall rate of catalysis (and hence the extent of inhibition) because there is a quantifiable correlation between E(m)(0) (that increases in the presence of l-Trp) and the rate constant for O(2) binding. This means that the initial formation of ferric superoxide (Fe(3+)–O(2)(•–)) from Fe(2+)-O(2) becomes thermodynamically less favorable as substrate binds, and we propose that it is the slowing down of this oxidation step at higher concentrations of substrate that is the origin of the inhibition. In contrast, we show that regeneration of the ferrous enzyme (and formation of NFK) in the final step of the mechanism, which formally requires reduction of the heme, is facilitated by the higher reduction potential in the substrate-bound enzyme and the two constants (k(cat) and E(m)(0)) are shown also to be correlated. Thus, the overall catalytic activity is balanced between the equal and opposite dependencies of the initial and final steps of the mechanism on the heme reduction potential. This tuning of the reduction potential provides a simple mechanism for regulation of the reactivity, which may be used more widely across this family of enzymes. American Chemical Society 2012-02-02 2012-02-15 /pmc/articles/PMC3280726/ /pubmed/22299628 http://dx.doi.org/10.1021/ja208694g Text en Copyright © 2012 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Efimov, Igor
Basran, Jaswir
Sun, Xiao
Chauhan, Nishma
Chapman, Stephen K.
Mowat, Christopher G.
Raven, Emma Lloyd
The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title_full The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title_fullStr The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title_full_unstemmed The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title_short The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
title_sort mechanism of substrate inhibition in human indoleamine 2,3-dioxygenase
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280726/
https://www.ncbi.nlm.nih.gov/pubmed/22299628
http://dx.doi.org/10.1021/ja208694g
work_keys_str_mv AT efimovigor themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT basranjaswir themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT sunxiao themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT chauhannishma themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT chapmanstephenk themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT mowatchristopherg themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT ravenemmalloyd themechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT efimovigor mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT basranjaswir mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT sunxiao mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT chauhannishma mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT chapmanstephenk mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT mowatchristopherg mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase
AT ravenemmalloyd mechanismofsubstrateinhibitioninhumanindoleamine23dioxygenase